EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis

Dejan Jakimovski iD, Robert Zivadinov iD, Ferhan Qureshi, Murali Ramanathan, Bianca Weinstock-Guttman iD, Eleonora Tavazzi, Michael G Dwyer iD, Niels Bergsland iD

Biomolecules · 2024

DOI: 10.3390/biom14070824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Dejan Jakimovski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State Univer…. Hauptthemen laut MEDLINE: Biomarkers, Multiple Sclerosis, Choroid Plexus, Magnetic Resonance Imaging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, OCTAVE Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased choroid plexus (CP) volume has been recently implicated as a potential predictor of worse multiple sclerosis (MS) outcomes. The biomarker signature of CP changes in MS are currently unknown. To determine the blood-based biomarker characteristics of the cross-sectional and longitudinal MRI-based CP changes in a heterogeneous group of people with MS (pwMS), a total of 202 pwMS (148 pwRRMS and 54 pwPMS) underwent MRI examination at baseline and at a 5-year follow-up. The CP was automatically segmented and subsequently refined manually in order to obtain a normalized CP volume. Serum samples were collected at both timepoints, and the concentration of 21 protein measures relevant to MS pathophysiology were determined using the Olink™ platform. Age-, sex-, and BMI-adjusted linear regression models explored the cross-sectional and longitudinal relationships between MRI CP outcomes and blood-based biomarkers. At baseline, there were no significant proteomic predictors of CP volume, while at follow-up, greater CP volume was significantly associated with higher neurofilament light chain levels, NfL (standardized β = 0.373, p = 0.001), and lower osteopontin levels (standardized β = −0.23, p = 0.02). Higher baseline GFAP and lower FLRT2 levels were associated with future 5-year CP % volume expansion (standardized β = 0.277, p = 0.004 and standardized β = −0.226, p = 0.014, respectively). The CP volume in pwMS is associated with inflammatory blood-based biomarkers of neuronal injury (neurofilament light chain; NfL) and glial activation such as GFAP, osteopontin, and FLRT2. The expansion of the CP may play a central role in chronic and compartmentalized inflammation and may be driven by glial changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMultiple SclerosisChoroid PlexusMagnetic Resonance ImagingHumansFemaleMaleAdultMiddle AgedCross-Sectional StudiesNeurofilament ProteinsOsteopontinProteomicsGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

GFAPNfLchoroid plexusmultiple sclerosisserum biomarkers

Substanzen

BiomarkersNeurofilament ProteinsOsteopontinGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA.
  • Wynn Hospital, Mohawk Valley Health System (MVHS), Utica, NY 13502, USA.
  • Center for Biomedical Imaging at the Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY 14203, USA.
  • Octave Bioscience, Menlo Park, CA 94025, USA.
  • Department of Pharmaceutical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA.
  • Department of Neurology, Jacobs Comprehensive MS Treatment and Research Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14203, USA.

ORCID-Profile: Dejan Jakimovski, Robert Zivadinov, Bianca Weinstock-Guttman, Michael G Dwyer, Niels Bergsland

Förderung

  • NCATS NIH HHS
  • OCTAVE Biosciences

Zitieren

APA

Jakimovski, D., Zivadinov, R., Qureshi, F., Ramanathan, M., Weinstock-Guttman, B., Tavazzi, E., Dwyer, M. G., & Bergsland, N. (2024). Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis. Biomolecules. https://doi.org/10.3390/biom14070824

Vancouver

Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E, et al. Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis. Biomolecules. 2024. doi:10.3390/biom14070824

BibTeX
@article{Jakimovski2024,
  author = {Jakimovski, Dejan and Zivadinov, Robert and Qureshi, Ferhan and Ramanathan, Murali and Weinstock-Guttman, Bianca and Tavazzi, Eleonora and Dwyer, Michael G and Bergsland, Niels},
  title = {Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14070824}
}
Kostenlos starten →